top of page


Country 2 Country 4 Cancer
A team of 10 novice bikers from Bristol-Myers Squibb participated in Country 2 Country 4 Cancer, an epic annual cycling event which set...


Introducing Team UK! #C2C4Cancer
Today we say hello to Lindsay Hall and Kerry Johnson, our two Chester riders helping us in the fight against rare and less common...
APPGC Cancer Strategy Inquiry – August 2017
Cancer52 submitted written evidence to the APPGC Cancer Strategy inquiry, as the Cancer Strategy Achieving World-Class Cancer Outcomes: A...
11 July 2017 All Members Meeting
The agenda has now been finalised for the next Cancer52 All Members Meeting taking place on Tuesday 11th July from 9.30am to 12.30pm in...
General Election 2017: Cancer52 Calls to Action
In the run up to the 2017 General Election Cancer52 has produced a one pager document on its ‘Calls to Action’. In the 2015 election...

“Clinical Nurse Specialists working with people with rare and less common cancers”
Available from 6th December 2016 to mark the Cancer52 session at Britain Against Cancer – a new report from Cancer52 on the role of the...
All Members Meeting 25 April 2017
We enjoyed a stimulating and informative meeting with presentations from Chris Carrigan on using data, Kathy Oliver on Eurocan and Sasha...
Cancer Strategy recommendations grid April
As at April 2017, Cancer52 has published a review of the progress of the recommendations contained in ‘Achieving World Class Cancer...
Joint Cancer52 workshop with NHSE to respond to Recommendation 40 (regarding MDTs for rarer cancers)
We held this on 15th March and my thanks to all the Cancer52 members who attended. Slides from the presentation are here.
NICE Consultation on improving how patients and the public can help develop NICE guidance and standa
Cancer52 has responded on the above consultation (February 2017) and full response can be found here. The topic was discussed at the...
bottom of page